✦ LIBER ✦

Can stem blood cell transplantation be an adjuvant treatment for primary cardiac lymphoma?

✍ Scribed by Reinaldo B. Bestetti; Carlos E. Miguel

Publisher: Carden Jennings Publishing
Year: 2007
Tongue: English
Weight: 34 KB
Volume: 86
Category: Article
ISSN: 0925-5710
DOI: 10.1007/bf03006935

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy with hematopoieti

High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma

✍ Christopher J. Campen; Rebecca L. Tombleson; Myke R. Green 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 222 KB

Non-cryopreserved peripheral blood stem

Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis

✍ Ruiz-Argüelles, Guillermo J.; Ruiz-Argüelles, Alejandro; Pérez-Romano, Beatriz; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB 👁 1 views

We have prospectively performed peripheral blood stem cell autotransplants in six patients with hematological malignancies on an entirely outpatient basis. Patients were conditioned with high-dose melphalan and received a median of 4.2 × 10 8 /kg noncryopreserved, non-purged mononuclear cells, conta

Successful treatment of advanced periphe

Successful treatment of advanced peripheral T-cell lymphoma with an angiocentric growth pattern complicated with hemophagocytic syndrome by high-dose chemotherapy and autologous peripheral blood stem cell transplantation

✍ T. Sato; K. Kogawa; S. Iyama; D. Kobayashi; Y. Sato; K. Kuribayashi; K. Takada; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 731 KB

High-dose chemotherapy and autologous pe

High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases

✍ J. Tsuchiyama; K. Imajo; T. Yoshino; N. Nanba; A. Toyota; C. Yoshida; K. Fujii; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 119 KB

The Hyper-CVAD chemotherapy regimen has

The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization

✍ Colm Keane; Simon Gibbs; John F Seymour; Anthony K Mills; Karen Grimmett; Rosita 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract The Hyper‐CVAD chemotherapy regimen is being increasingly applied to a number of haematological malignancies. We assessed the impact of Hyper‐CVAD on peripheral blood stem cell (PBSC) yields and examined the optimal timing of PBSC collection when using this regimen. Seventy‐four consecu